REGINA MANGANO: Open Payments
NPI 1760197230 · MULLICA HILL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$355 in 19 payments from 8 companies in 2025. Trend: 2023 $14 · 2024 $695 · 2025 $355
Food & beverage: $355
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $90 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $87 |
| Novo Nordisk Inc | 4 | $73 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Kestra Medical Technology Services, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $17 |
| PFIZER INC. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: Kerendia, JARDIANCE, LEQVIO, Wegovy, Ozempic, Assure WCD, REPATHA, ELIQUIS.
Industry payments across NJ — which companies pay providers there.
